The pharmaceutical industry isn’t delivering innovation the public needs—but drug makers are reaping the profits they demand. It’s time to rethink the system.
Sign up to receive updates about our work in Health.
The pharmaceutical industry isn’t delivering innovation the public needs—but drug makers are reaping the profits they demand. It’s time to rethink the system.
Despite advances in medical science, affordable safe and effective medicines remain inaccessible to billions of people worldwide. The Open Society Foundations support efforts to increase access to essential medicines for people in low-resource countries, especially for poor and marginalized populations.
More on the ideas and programs behind our work: Access to Medicines. ▼ Hide info ▲
Instead of telling women not to get pregnant, Brazil should be implementing supports for them.
Dr. M.R. Rajagopal, founder of Pallium India, is working state by state with health care professionals to make palliative care more pervasive.
This brief summarizes key concerns about the impact of the Global Fund’s withdrawal from countries that have already experienced funding reductions.
With more affordable medicines, pervasive illnesses like hepatitis C can be treated more widely.
Why is it still illegal to take a pill the World Health Organization calls an essential medicine?
A U.S. Senate investigation concludes that a blockbuster hepatitis C drug was priced to drive profits, not innovation. But that’s just the tip of the iceberg.